Skip to main content
Monday, November 16, 2026Nov 16

Wall Street slips amid worries about worsening pandemic

In this photo provided by the New York Stock Exchange, a trader works on the floor during the IPO of Omnichannel Acquisition Corporation, Friday, Nov. 20, 2020. U.S. stocks are pulling a bit lower in midday trading Friday as worries about the worsening pandemic weigh on rising optimism about a coming coronavirus vaccine. (Courtney Crow/New York Stock Exchange via AP)
In this photo provided by the New York Stock Exchange, a trader works on the floor during the IPO of Omnichannel Acquisition Corporation, Friday, Nov. 20, 2020. U.S. stocks are pulling a bit lower in midday trading Friday as worries about the worsening pandemic weigh on rising optimism about a coming coronavirus vaccine. (Courtney Crow/New York Stock Exchange via AP)

U.S. stocks are pulling a bit lower in afternoon trading Friday as worries about the worsening pandemic undercut growing optimism about a coming coronavirus vaccine.

The S&P 500 fell 0.2%, as of 2:30 p.m. Eastern time. The Dow Jones Industrial Average was down 132 points, or 0.5%, at 29,349, and the Nasdaq composite rose 0.2%. Treasury yields were holding steady, while stock markets around the world made only modest moves.

Wall Street has suddenly begun to teeter-totter this week after a big November rally swept both the S&P 500 and Dow to record highs. Evidence is piling up for investors both for hope about the economy’s prospects next year and for fear about the damage accruing in the shorter term. The S&P 500 is on track for a 0.3% dip this week, on the heels of a 7.3% weekly surge followed by a 2.2% climb.

“It’s a market concerned about growth,” said Quincy Krosby, chief market strategist at Prudential Financial. “That’s the big uncertainty.”

Adding to the optimistic side of the ledger Friday was Pfizer and BioNTech saying they’ll submit an application with U.S. regulators for emergency use of their vaccine candidate. Data suggests it may be 95% effective at preventing mild to severe COVID-19 disease.